AI Analysis – Experimental
Mandates a $35 monthly cap on co-pays or coinsurance for at least one insurer-selected insulin product in each major category, with annual adjustments for inflation, to improve insulin affordability for Michigan residents.
Introduced in the House
June 17, 2026
Introduced
by
Rep. Jennifer Conlin (D-48)
and 22 co-sponsors
Co-sponsored by Reps.
Mai Xiong (D-13), Kelly Breen (D-21), Samantha Steckloff (D-19), Regina Weiss (D-5), Matt Longjohn (D-40), Julie Brixie (D-73), Kara Hope (D-74), Jasper Martus (D-69), Penelope Tsernoglou (D-75), Matt Koleszar (D-22), Jason Morgan (D-23), Tonya Myers Phillips (D-7), Jimmie Wilson (D-32), Joey Andrews (D-38), Carrie Rheingans (D-47), Erin Byrnes (D-15), John Fitzgerald (D-83), Jason Hoskins (D-18), Cynthia Neeley (D-70), Amos O’Neal (D-94), Denise Mentzer (D-61) and Natalie Price (D-6)
Referred to the Committee on Insurance
